These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4328377)

  • 1. Amelioration of the side effects of cyclophosphamide.
    Hussey JL; Kisken WA
    Surg Forum; 1970; 21():109-11. PubMed ID: 4328377
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of camptothecin (NSC-100880).
    Schaeppi U; Fleischman RW; Cooney DA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):25-36. PubMed ID: 4213507
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
    Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
    Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isogeneic bone marrow transplantation in rats previously treated with cyclophosphamide (preliminary report)].
    Hernández P; Carmena A; Callejas J
    Rev Clin Esp; 1972 Mar; 124(6):587-90. PubMed ID: 4602405
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ampicillin-cloxacillin combination with regard to the study of acute and subacute toxicity].
    Dominici A; Ravagnan G
    Antibiotica; 1969 Dec; 7(4):282-91. PubMed ID: 5407464
    [No Abstract]   [Full Text] [Related]  

  • 6. Symposium on bone marrow transplantation: experimental aspects in canines.
    Thomas ED; Storb R; Epstein RB; Rudolph RH
    Transplant Proc; 1969 Mar; 1(1):31-3. PubMed ID: 5002661
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival of canine renal allografts after antilymphocytic serum and bone-marrow treatment.
    Caridis DT; Lieogeois A; Barret I; Lytle BW; Monaco AP
    Br J Surg; 1972 Apr; 59(4):311. PubMed ID: 4553597
    [No Abstract]   [Full Text] [Related]  

  • 8. [How to obtain specific pathogen-free mice by the antibiotic decontamination method].
    Dushkin VA; Intizarov MM; Podoprigora GI
    Antibiotiki; 1971 Sep; 16(9):819-22. PubMed ID: 4333291
    [No Abstract]   [Full Text] [Related]  

  • 9. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan.
    Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH
    Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma.
    Brown CH; Ziegler JL; Templeton C; Carbone PP
    Cancer; 1970 Aug; 26(2):462-7. PubMed ID: 5451221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].
    Tong XZ; Xu DR; Zou WY; Li J; Luo SK; Peng AH; Zhang GC; Zheng D
    Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
    Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
    Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
    Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
    Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in the inbred rat. 18. Effect of cyclophosphamide on acute rejection and long survival of recipients.
    Kawabe K; Guttmann RD; Levin B; Merrill JP; Lindquist RR
    Transplantation; 1972 Jan; 13(1):21-6. PubMed ID: 4550343
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
    Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trial of allogenic bone marrow graft in rats after conditioning with cyclophosphamide].
    Kolar V; Kolarova M
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):780-2. PubMed ID: 4904576
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
    Bacigalupo A
    Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 20. Ampicillin-associated diarrhea: effect of dosage and route of administration.
    Phillips JA; Lovejoy FH; Matsumiya Y
    Pediatrics; 1976 Dec; 58(6):869-72. PubMed ID: 995516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.